Tamarack Advisers, LP historic quarter change: USA Everything Else, New
In partnership units, exchange-traded notes and anything else (listed in the US), over 3 quarters from 2015-12-31 to 2023-12-31, Tamarack Advisers, LP opened 17 positions, added to 0, reduced 0 and sold out of 31.
- Q3 2016: Stock ENDOLOGIX INC 3.250% 11/01/20 CVT; Country of operation —; Class Note; Shares before 0.
- Q2 2016: Stock ENDOLOGIX INC; Country of operation —; Class Equity; Shares before 0.
- Q2 2016: Stock NXSTAGE MEDICAL INC; Country of operation —; Class Equity; Shares before 0.
- Q2 2016: Stock IMPRIVATA INC; Country of operation —; Class Equity; Shares before 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1661462), 3 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-09); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2015-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | ENDOLOGIX INC 3.250% 11/01/20 CVT
CUSIP 29266SAB2 | | Note | 0 | 2,000,000 | +2,000,000 | $0 | $2,649,000 | +$2,649,000 | 2016-11-09 |
|---|
| Q2 2016 | ENDOLOGIX INC
CUSIP 29266S106 | | Equity | 0 | 2,910,000 | +2,910,000 | $0 | $36,259,000 | +$36,259,000 | 2016-08-15 |
|---|
| Q2 2016 | NXSTAGE MEDICAL INC
CUSIP 67072V103 | | Equity | 0 | 1,200,000 | +1,200,000 | $0 | $26,016,000 | +$26,016,000 | 2016-08-15 |
|---|
| Q2 2016 | IMPRIVATA INC
CUSIP 45323J103 | | Equity | 0 | 1,309,800 | +1,309,800 | $0 | $18,337,000 | +$18,337,000 | 2016-08-15 |
|---|
| Q2 2016 | ARIAD PHARMACEUTICALS INC
CUSIP 04033A100 | | Equity | 0 | 2,100,000 | +2,100,000 | $0 | $15,519,000 | +$15,519,000 | 2016-08-15 |
|---|
| Q2 2016 | SPECTRANETICS CORP
CUSIP 84760C107 | | Equity | 0 | 714,200 | +714,200 | $0 | $13,363,000 | +$13,363,000 | 2016-08-15 |
|---|
| Q2 2016 | STERIS PLC
CUSIP 859152100 | United States | Equity | 0 | 185,000 | +185,000 | $0 | $12,719,000 | +$12,719,000 | 2016-08-15 |
|---|
| Q2 2016 | LUMINEX CORP
CUSIP 55027E102 | | Equity | 0 | 526,000 | +526,000 | $0 | $10,641,000 | +$10,641,000 | 2016-08-15 |
|---|
| Q2 2016 | LABORATORY CRP OF AMER HLDGS
CUSIP 50540R409 | United States | Equity | 0 | 75,000 | +75,000 | $0 | $9,770,000 | +$9,770,000 | 2016-08-15 |
|---|
| Q2 2016 | NEVRO CORP
CUSIP 64157F103 | United States | Equity | 0 | 82,200 | +82,200 | $0 | $6,063,000 | +$6,063,000 | 2016-08-15 |
|---|
| Q2 2016 | SAGENT PHARMACEUTICALS INC
CUSIP 786692103 | | Equity | 0 | 259,336 | +259,336 | $0 | $3,885,000 | +$3,885,000 | 2016-08-15 |
|---|
| Q2 2016 | CORIUM INTERNATIONAL INC
CUSIP 21887L107 | | Equity | 0 | 1,075,000 | +1,075,000 | $0 | $3,730,000 | +$3,730,000 | 2016-08-15 |
|---|
| Q2 2016 | PDCO US 10/21/16 C42
CUSIP 703395103 | United States | Listed Option | 0 | 4,750 | +4,750 | $0 | $2,850,000 | +$2,850,000 | 2016-08-15 |
|---|
| Q2 2016 | ENDOLOGIX INC 3.250% 11/01/20 CVT
CUSIP 29266SAB2 | | Bond Convertible | 0 | 2,000,000 | +2,000,000 | $0 | $2,624,000 | +$2,624,000 | 2016-08-15 |
|---|
| Q2 2016 | RELYPSA INC
CUSIP 759531106 | | Equity | 0 | 94,475 | +94,475 | $0 | $1,748,000 | +$1,748,000 | 2016-08-15 |
|---|
| Q2 2016 | STREAMLINE HEALTH SOLUTIONS
CUSIP 86323X106 | United States | Equity | 0 | 1,138,000 | +1,138,000 | $0 | $1,366,000 | +$1,366,000 | 2016-08-15 |
|---|
| Q2 2016 | MODEL N INC
CUSIP 607525102 | United States | Equity | 0 | 20,000 | +20,000 | $0 | $267,000 | +$267,000 | 2016-08-15 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |